Andrew Kleinberg
Regeneron (United States)(US)
Publications by Year
Research Areas
Protein purification and stability, Monoclonal and Polyclonal Antibodies Research, Melanoma and MAPK Pathways, Cancer-related Molecular Pathways, Growth Hormone and Insulin-like Growth Factors
Most-Cited Works
- → One-Pot Friedländer Quinoline Synthesis: Scope and Limitations(2010)36 cited
- → Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics(2013)26 cited
- → Discovery of potent, selective and orally bioavailable imidazo[1,5-a]pyrazine derived ACK1 inhibitors(2012)20 cited
- → Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1(2013)20 cited
- → Discovery of Novel Insulin-Like Growth Factor-1 Receptor Inhibitors with Unique Time-Dependent Binding Kinetics(2013)17 cited
- → Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy(2010)16 cited
- → Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases(2013)15 cited
- → Simple Addition of Glycine in Trifluoroacetic Acid-Containing Mobile Phases Enhances the Sensitivity of Electrospray Ionization Mass Spectrometry for Biopharmaceutical Characterization(2020)12 cited
- → Fast protein sequencing of monoclonal antibody by real-time digestion on emitter during nanoelectrospray(2019)10 cited
- → Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR(2010)9 cited